🚀
Enjoy a 7-Day Free Trial Thru May 03, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
XOMA Corp (NAS:XOMA)
News
XOMA Corp
NAS
:XOMA (USA) Â
$ 25.36
-0.28 (-1.09%)
10:08 PM EST
P/E:
At Loss
P/B:
3.29
Market Cap:
$ 295.06M
Enterprise V:
$ 269.37M
Volume:
6.46K
Avg Vol (2M):
17.92K
Warning! GuruFocus detected 5 Severe warning signs with XOMA.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
6.46K
Market Cap $:
295.06M
PE Ratio:
At Loss
Avg Vol (2M):
17.92K
Enterprise Value $:
269.37M
PB Ratio:
3.29
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocks™
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
XOMA Corp (NAS:XOMA) Stock News, Headlines & Updates
XOMA Corp Stock News from GuruFocus
Total 83
1
2
3
Apr 25, 2024
XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
Marketwired
•
7:00am
Mar 08, 2024
XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023
GuruFocus Research
•
7:12am
Feb 09, 2024
XOMA Corp at H.C. Wainwright BioConnect Investor Conference Transcript
GuruFocus Research
•
12:22pm
XOMA Corp Annual Shareholders Meeting Transcript
GuruFocus Research
•
12:22pm
XOMA Corp Annual Shareholders Meeting Transcript
GuruFocus Research
•
12:22pm
XOMA Corp Annual Shareholders Meeting Transcript
GuruFocus Research
•
12:22pm
XOMA Corp at Cowen Health Care Conference Transcript
GuruFocus Research
•
12:22pm
Sep 25, 2023
XOMA Declares Quarterly Preferred Stock Dividends
Marketwired
•
7:00am
Sep 06, 2023
XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference
Marketwired
•
7:00am
Aug 08, 2023
XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy
Marketwired
•
7:00am
Jun 23, 2023
XOMA Added to the Russell 2000® and Russell 3000® Indexes
Marketwired
•
6:00pm
Jun 22, 2023
XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset
Marketwired
•
7:00am
May 27, 2023
Insider Buying: Interim CEO Owen Hughes Acquires 2,000 Shares of XOMA Corp
GuruFocus Research
•
1:12pm
May 26, 2023
Insider Buying: Interim CEO Owen Hughes Acquires 2,000 Shares of XOMA Corp (XOMA)
GuruFocus Research
•
1:03pm
Jan 07, 2023
XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Stock market mentor
•
6:00pm
Dec 22, 2022
XOMA Declares Quarterly Preferred Stock Dividends
Tiesvg
•
7:00am
Jun 20, 2022
XOMA Declares Quarterly Preferred Stock Dividends
GuruFocusNews
•
7:27am
Jun 16, 2022
XOMA to Present at H.C. Wainwright Global Investment Conference
GuruFocusNews
•
4:10pm
Jun 06, 2022
XOMA to Present at H.C. Wainwright Global Investment Conference
GuruFocusNews
•
4:09pm
May 17, 2022
XOMA to Present at H.C. Wainwright Global Investment Conference
GuruFocusNews
•
3:07pm
Mar 21, 2022
XOMA Declares Quarterly Preferred Stock Dividends
GuruFocusNews
•
7:00am
Mar 10, 2022
XOMA to Present at Oppenheimer's 32nd Annual Healthcare Conference
GuruFocusNews
•
7:00am
Feb 17, 2022
XOMA to Present at Aegis Capital Corp Investor Conference
GuruFocusNews
•
7:00am
Dec 23, 2021
XOMA Declares Quarterly Preferred Stock Dividends
GuruFocusNews
•
7:00am
Dec 21, 2021
XOMA to Present at Upcoming Investor Conferences
GuruFocusNews
•
7:00am
Dec 16, 2021
XOMA Announces Evolution of Company Leadership and Succession Planning
GuruFocusNews
•
7:00am
Nov 04, 2021
XOMA Earns $35 Million Milestone Payment as Anti-TGF? Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer
Don Li2
•
7:00am
Jul 15, 2021
XOMA Acquires Royalty and Milestone Interest in Checkmate's Vidutolimod (CMP-001) from Kuros Biosciences
Marketwired
•
3:00am
Jun 21, 2021
XOMA Declares Quarterly Preferred Stock Dividends
Marketwired
•
7:00am
Apr 18, 2021
XOMA Stock Is Estimated To Be Significantly Overvalued
GF Value
•
2:12am
Feb 24, 2021
XOMA to Present at Upcoming Investor Conferences
Marketwired
•
7:01pm
Jan 05, 2021
XOMA to Present at H.C. Wainwright Virtual BioConnect 2021 and Biotech Showcase Digital Conferences
Marketwired
•
7:00pm
Dec 22, 2020
XOMA Announces Exercise of Green Shoe Option and Closes Preferred Stock Offering
Marketwired
•
7:01pm
Dec 17, 2020
Xoma Corp (XOMA) SVP, Finance & CFO Thomas M. Burns Sold $621,150 of Shares
GuruFocus Research
•
4:15pm
Dec 11, 2020
XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock
Marketwired
•
7:00pm
Dec 10, 2020
XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock
Marketwired
•
7:01am
Nov 24, 2020
Xoma Corp (XOMA) CEO James R Neal Sold $656,200 of Shares
GuruFocus Research
•
5:15pm
Nov 16, 2020
XOMA Earns $2 Million Milestone from Takeda as Mezagitamab Advances into Phase 2 Development
Marketwired
•
7:01am
Nov 11, 2020
XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement
Marketwired
•
7:01am
Nov 03, 2020
XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance
Marketwired
•
7:01am
Total 83
1
2
3
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news